跳至主要内容
临床试验/NCT02310035
NCT02310035已完成不适用

Observational Study on the Course of Plasma Glutamine Levels During Critial Illness

Medical Centre Leeuwarden1 个研究点 分布在 1 个国家目标入组 178 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
178
试验地点
1
主要终点
glutamine in serum

研究概览

简要总结

Blood sampled for standard evaluation will be used for determination of plasma glutamine by Bioprofile Flex Glutamine Sensor at ICU admission

详细描述

All patients who are admitted to the ICU after elective surgery and non-elective admissions. In both groups a total of 80 patients will be included.

(In the trials we mentioned in the introduction 80, 174 and 66 patients were included. In the study performed by Oudemans-van Straaten a decent distribution between lower and higher levels of glutamine was achieved in 80 non-elective patients.) Exclusion criteria are patients younger then 18 years and patients who need total parenteral nutrition (TPN).

The patients will receive standard care during their treatment on the ICU. Blood sampled for standard evaluation will be used for determination of plasma glutamine by Bioprofile Flex Glutamine Sensor at ICU admission. Hereafter plasma glutamine will be measured daily, a plasma sample will be taken from a standard evaluation blood sample at 6.00 am during admission on the ICU.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all patients admitted to the ICU

排除标准

  • younger then 18 years and patients who need total parenteral nutrition

结局指标

主要结局

glutamine in serum

时间窗: from admission up to 8 days

glutamine level at admission and during ICU stay daily

次要结局

未报告次要终点

研究者

发起方
Medical Centre Leeuwarden
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matty Koopmans

MSc

Medical Centre Leeuwarden

研究点 (1)

Loading locations...

相似试验